Department of Cardiovascular Sciences and National Institute for Health Research Leicester Biomedical Research Unit in Cardiovascular Medicine, University of Leicester, Glenfield Hospital, Leicester, UK.
Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, UK.
Br J Surg. 2019 Feb;106(3):181-189. doi: 10.1002/bjs.11001. Epub 2018 Oct 17.
The aim was to investigate whether preoperative weight loss results in improved clinical outcomes in surgical patients with clinically significant obesity.
This was a systematic review and aggregate data meta-analysis of RCTs and cohort studies. PubMed, MEDLINE, Embase and CINAHL Plus databases were searched from inception to February 2018. Eligibility criteria were: studies assessing the effect of weight loss interventions (low-energy diets with or without an exercise component) on clinical outcomes in patients undergoing any surgical procedure. Data on 30-day or all-cause in-hospital mortality were extracted and synthesized in meta-analyses. Postoperative thromboembolic complications, duration of surgery, infection and duration of hospital stay were also assessed.
A total of 6060 patients in four RCTs and 12 cohort studies, all from European and North American centres, were identified. Most were in the field of bariatric surgery and all had some methodological limitations. The pooled effect estimate suggested that preoperative weight loss programmes were effective, leading to significant weight reduction compared with controls: mean difference -7·42 (95 per cent c.i. -10·09 to -4·74) kg (P < 0·001). Preoperative weight loss interventions were not associated with a reduction in perioperative mortality (odds ratio 1·41, 95 per cent c.i. 0·24 to 8·40; I = 0 per cent, P = 0·66) but the event rate was low. The weight loss groups had shorter hospital stay (by 27 per cent). No differences were found for morbidity.
This limited preoperative weight loss has advantages but may not alter the postoperative morbidity or mortality risk.
本研究旨在探讨对于临床显著肥胖的手术患者,术前减重是否能改善临床结局。
本研究为系统评价和汇总分析 RCT 和队列研究。检索了 PubMed、MEDLINE、Embase 和 CINAHL Plus 数据库,检索时间截至 2018 年 2 月。纳入标准为:评估体重减轻干预(含或不含运动成分的低能量饮食)对任何手术患者临床结局影响的研究。提取并汇总了 30 天或全因院内死亡率、术后血栓栓塞并发症、手术持续时间、感染和住院时间的数据。
共纳入 4 项 RCT 和 12 项队列研究的 6060 例患者,这些研究均来自欧洲和北美中心,研究领域主要为减重手术,但都存在一定的方法学局限性。汇总的效应估计表明,与对照组相比,术前体重减轻方案有效,可显著减轻体重:平均差值 -7.42(95%置信区间-10.09 至-4.74)kg(P<0.001)。术前体重减轻干预与围手术期死亡率降低无关(比值比 1.41,95%置信区间 0.24 至 8.40;I = 0%,P = 0.66),但事件发生率较低。体重减轻组的住院时间缩短了 27%。两组的发病率无差异。
这种有限的术前减重有一定优势,但可能不会改变术后发病率或死亡率风险。